{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From randomization (Day -5) up to 8 years","title":"Progression-Free Survival on First-Line Treatment for Multiple Myeloma (PFS2)","type":"SECONDARY"}